Back to search

United Kingdom· GB-APID-36809711000001107

Vesicare 5mg tablets

A solifenacin product containing solifenacin, registered in United Kingdom by Pharmaram Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC G04BD08

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedVesicare 5mg tabletsATCG04BD08REGISTER NO.GB-APID-3680971100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Solifenacin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04BD08 (solifenacin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose

Solifenacin · ATC G04BD08

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of solifenacin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.25 in France to $0.92 in Switzerland — a ×3.7 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Solifenacin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.92
  • ES Spain$0.77
  • IT Italy$0.59
  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Solifenacin
Manufacturer
Pharmaram Ltd
Country
United Kingdom (GB)
ATC code
G04BD08
ATC class
Solifenacin
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    05060666560503
  • gtin
    05060666560725

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

315 interactions on record for solifenacin.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Solifenacin · interactions on record

315 records

  • 50 severe
  • 210 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe

52 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Solifenacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All solifenacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Solifenacin +pharma, Solifenacin 1a Pharma
  • Belgium · Pelvicare, Solifenacin Ab
  • Bulgaria · Truzor, Асолфена
  • Cyprus · Saprax, Solifenacin Accord
  • Czechia · Arusol, Asolfena
  • Germany · Solifemin, Solifenacin 1 A Pharma
  • Denmark · Solifenacin "sandoz", Solifenacin Krka
  • Estonia · Asolfena, Solifenacin Nobel
  • Spain · Dicrisol, Sincal
  • Finland · Solifenacin Accord, Solifenacin Krka
  • France · Solifenacine Accord, Solifenacine Arrow
  • Greece · Cecure, Nacerfin
  • Croatia · Asolfena, Beloflux
  • Hungary · Asolfena, Belsanor
  • Ireland · Solifenacin Clonmel, Solifenacin Succinate Accord Healthcare Ireland
  • Iceland · Solifenacin Alvogen, Solifenacin Krka
  • Italy · Incoves, Orodax
  • Liechtenstein · Vesicare
  • Lithuania · Asolfena, Gardurin
  • Luxembourg · Pelvicare, Solifenacin Ratiopharm
  • Latvia · Asolfena, Gardurin
  • Malta · Solifenacin Pharmsol, Vesicare
  • Netherlands · Solifenacinesuccinaat Accord, Solifenacinesuccinaat Aurobindo
  • Norway · Solifenacin Accord, Solifenacin Krka
  • Poland · Adablok, Afenix
  • Portugal · Blaxi, Solifenacina Alter
  • Romania · Asolfena, Solifenacin Msn Laboratories
  • Sweden · Solifenacin Accord, Solifenacin Glenmark
  • Slovenia · Asolfena, Solifenacin Lek
  • Slovakia · Aristissa, Arusol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bfc79315-3efc-4293-a2d8-9fdcc64e4363
GET /v1/drugs/bfc79315-3efc-4293-a2d8-9fdcc64e4363?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "36809711000001107",
  "desc": "Vesicare 5mg tablets (Pharmaram Ltd)",
  "form": "Oral tablet",
  "vpid": "42042911000001105",
  "source": "dmd",
  "vtm_id": "777585001",
  "strength": "5 mg",
  "substance": "Solifenacin",
  "ingredient": "Solifenacin succinate",
  "supplier_code": "36811311000001106"
}

See everything about solifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.